Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2023
Portfolio Pulse from Benzinga Insights
Benzinga has released its top ratings upgrades and downgrades for June 23, 2023, including several companies such as Neste Corp, Wayfair Inc, Evotec SE, Ventas Inc, and Principal Financial Group Inc receiving upgrades, while others like Humana Inc, Sarepta Therapeutics Inc, Under Armour Inc, and Accenture PLC were downgraded. Additionally, new coverage was initiated for companies like Fusion Pharmaceuticals Inc, Gambling.com Group Ltd, Valvoline Inc, and Floor & Decor Holdings Inc.
June 23, 2023 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accenture PLC's rating was downgraded from Outperform to Market Perform by TD Cowen. The stock has a 52-week-high of $327.93 and a 52-week-low of $242.80, with a closing price of $307.25 at the end of the last trading period.
The downgrade from Outperform to Market Perform by TD Cowen indicates a negative outlook for Accenture PLC's stock in the short term. The stock's current performance, with a closing price of $307.25, is closer to its 52-week-high, which suggests potential for decline.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Humana Inc's rating was downgraded from Buy to Hold by Argus Research. The stock has a 52-week-high of $571.01 and a 52-week-low of $435.00, with a closing price of $456.44 at the end of the last trading period.
The downgrade from Buy to Hold by Argus Research indicates a negative outlook for Humana Inc's stock in the short term. The stock's current performance, with a closing price of $456.44, is closer to its 52-week-low, which suggests potential for decline.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Sarepta Therapeutics Inc's rating was downgraded from Outperform to Neutral by Evercore ISI Group. The stock has a 52-week-high of $159.89 and a 52-week-low of $67.91, with a closing price of $123.92 at the end of the last trading period.
The downgrade from Outperform to Neutral by Evercore ISI Group indicates a negative outlook for Sarepta Therapeutics Inc's stock in the short term. The stock's current performance, with a closing price of $123.92, is closer to its 52-week-high, which suggests potential for decline.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Under Armour Inc's rating was downgraded from Overweight to Equal-Weight by Wells Fargo. The stock has a 52-week-high of $13.04 and a 52-week-low of $6.39, with a closing price of $7.35 at the end of the last trading period.
The downgrade from Overweight to Equal-Weight by Wells Fargo indicates a negative outlook for Under Armour Inc's stock in the short term. The stock's current performance, with a closing price of $7.35, is closer to its 52-week-low, which suggests potential for decline.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evotec SE's rating was upgraded from Equal-Weight to Overweight by Morgan Stanley. The stock has a 52-week-high of $15.04 and a 52-week-low of $7.80, with a closing price of $11.21 at the end of the last trading period.
The upgrade from Equal-Weight to Overweight by Morgan Stanley indicates a positive outlook for Evotec SE's stock in the short term. The stock's current performance, with a closing price of $11.21, is closer to its 52-week-high, which suggests potential for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Neste Corp's rating was upgraded from Underperform to Market Perform by TD Cowen. The stock has a 52-week-high of $26.03 and a 52-week-low of $18.70, with a closing price of $19.00 at the end of the last trading period.
The upgrade from Underperform to Market Perform by TD Cowen indicates a positive outlook for Neste Corp's stock in the short term. The stock's current performance, with a closing price of $19.00, is closer to its 52-week-low, which suggests potential for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Principal Financial Group Inc's rating was upgraded from Underperform to Hold by Jefferies. The stock has a 52-week-high of $96.12 and a 52-week-low of $61.06, with a closing price of $72.52 at the end of the last trading period.
The upgrade from Underperform to Hold by Jefferies indicates a positive outlook for Principal Financial Group Inc's stock in the short term. The stock's current performance, with a closing price of $72.52, is closer to its 52-week-high, which suggests potential for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Ventas Inc's rating was upgraded from Outperform to Strong Buy by Raymond James. The stock has a 52-week-high of $54.11 and a 52-week-low of $35.34, with a closing price of $44.49 at the end of the last trading period.
The upgrade from Outperform to Strong Buy by Raymond James indicates a positive outlook for Ventas Inc's stock in the short term. The stock's current performance, with a closing price of $44.49, is closer to its 52-week-high, which suggests potential for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Wayfair Inc's rating was upgraded from Underperform to Market Perform by MoffettNathanson. The stock has a 52-week-high of $76.28 and a 52-week-low of $28.13, with a closing price of $57.09 at the end of the last trading period.
The upgrade from Underperform to Market Perform by MoffettNathanson indicates a positive outlook for Wayfair Inc's stock in the short term. The stock's current performance, with a closing price of $57.09, is closer to its 52-week-high, which suggests potential for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100